Friedelin induces apoptosis in oral cancer: Insights from in vitro and in silico studies
Friedelin is an anticancer agent that has great potential for oral cancer treatment by modulating apoptotic signaling pathways and inducing apoptosis. Future studies should be conducted on the in vivo validation and clinical translation of Friedelin as a novel therapeutic candidate.
Authors
- Ramya Sekar (ORCID: https://orcid.org/0000-0003-0381-2859)
- Manikandan Anandhan (ORCID: https://orcid.org/0000-0002-7065-5884)
- Monisha Prasad (ORCID: https://orcid.org/0000-0003-2185-8121)
Institutions
- Meenakshi Academy of Higher Education and Research (IN)
- Meenakshi Ammal Dental College and Hospital (IN)
- Saveetha University (IN)
Publication Details
- Journal
- Journal of Oral Biology and Craniofacial Research
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1016/j.jobcr.2025.08.013
- Primary Topic
- Natural product bioactivities and synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00